|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,220.80 |
3.27% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$62,766.15 |
2.97% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$52,797.96 |
2.50% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$47,844.81 |
2.26% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,834.40 |
2.26% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$46,433.96 |
2.19% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,658.69 |
2.16% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$45,083.64 |
2.13% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$44,861.96 |
2.12% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,638.23 |
2.11% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,629.96 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,362.59 |
2.10% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$44,214.72 |
2.09% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,068.98 |
2.08% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$44,019.63 |
2.08% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$44,108.12 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,821.70 |
2.07% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,676.07 |
2.06% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$43,452.52 |
2.05% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$42,687.04 |
2.02% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,648.54 |
2.02% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$42,616.95 |
2.01% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,334.44 |
2.00% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$42,273.83 |
2.00% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,780.76 |
1.97% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$41,390.36 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,500.56 |
1.96% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$40,760.58 |
1.93% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,889.55 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$40,898.78 |
1.93% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$40,183.54 |
1.90% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,968.12 |
1.89% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,632.94 |
1.87% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$39,443.40 |
1.86% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$39,243.00 |
1.85% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,244.44 |
1.85% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,915.97 |
1.84% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$38,800.78 |
1.83% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,022.32 |
1.80% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,095.82 |
1.80% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,824.83 |
1.79% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,560.14 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,874.95 |
1.74% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,892.52 |
1.74% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,903.29 |
1.74% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,161.01 |
1.71% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$35,741.87 |
1.69% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$35,423.31 |
1.67% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$34,232.28 |
1.62% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,314.80 |
1.43% |
| US Dollar |
$USD |
|
2,890 |
$2,889.63 |
0.14% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Japanese Yen |
$JPY |
|
-1,740 |
($11.16) |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|